US Stock MarketDetailed Quotes

TBPH Theravance Biopharma

Watchlist

9.390
+0.030+0.32%

Close Mar 21 16:00 ET

9.390
0.0000.00%

Post 16:01 ET

464.53MMarket Cap-8.17P/E (TTM)

Theravance Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Theravance Biopharma Q4 2024 Earnings Date

Currency：USDFeb 26, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	17.09M	18.75M	+1.66M
Beat Est.	-2.69%	+6.77%	+9.72%
EPS	-0.20	-0.31	-0.11
Miss Est.	-17.66%	-82.35%	-55.08%

Analyst Rating

Buy

Mar 3, 2025

Theravance Biopharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 16.100M	--
--	2025/Q1	-- / 28.075M	--
Feb 26, 2025	2024/Q4	18.754M / 17.093M	--
Nov 12, 2024	2024/Q3	16.868M / 15.424M	--
Aug 5, 2024	2024/Q2	14.256M / 15.307M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 16.100M--

--2025/Q1-- / 28.075M--

Feb 26, 20252024/Q418.754M / 17.093M--

Nov 12, 20242024/Q316.868M / 15.424M--

Aug 5, 20242024/Q214.256M / 15.307M--

Unlock Free Earnings Estimates

Open Account

Theravance Biopharma Earnings Reports

Theravance Biopharma | 10-K: FY2024 Annual Report

Mar 7 06:16 ET

Theravance Biopharma | 8-K: Theravance Biopharma, Inc. Reports Record Fourth Quarter and Full Year 2024 Financial Results

Feb 26 16:17 ET

Theravance Biopharma | 10-Q: Q3 2024 Earnings Report

Nov 14, 2024 06:11 ET

Theravance Biopharma | 8-K: Theravance Biopharma, Inc. Reports Third Quarter 2024 Financial Results and Announces Initiatives to Unlock Shareholder Value

Nov 12, 2024 16:14 ET

Market Insights

Symbol Mini Chart % Chg

AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS